Coloplast A/S (CLPBY) Expected to Post Earnings on Tuesday

Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) is expected to be posting its results before the market opens on Tuesday, August 18th. Analysts expect the company to announce earnings of $0.10 per share and revenue of $1.1186 billion for the quarter.

Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a return on equity of 33.15% and a net margin of 7.46%.The firm had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.11 billion. On average, analysts expect Coloplast A/S to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Get Coloplast A/S alerts:

Coloplast A/S Stock Down 2.2%

CLPBY stock opened at $6.65 on Tuesday. Coloplast A/S has a 12 month low of $5.64 and a 12 month high of $10.03. The company has a market cap of $14.99 billion, a price-to-earnings ratio of 47.50, a price-to-earnings-growth ratio of 2.15 and a beta of 0.13. The company has a fifty day moving average price of $6.16 and a 200 day moving average price of $6.74. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.75 and a quick ratio of 1.09.

Analysts Set New Price Targets

Separately, Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Coloplast A/S presently has a consensus rating of “Hold”.

View Our Latest Stock Report on Coloplast A/S

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.

Read More

• Five stocks we like better than Coloplast A/S
• SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
• 3 Dividend Champion Utilities for a Market That Can’t Sit Still
• These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
• First Solar’s Profit Engine Faces a New Policy Test in Washington

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.